Spotlight on Pegfilgrastim in Chemotherapy-Induced Neutropenia

被引：0
|
作者：
James E. Frampton
Gillian M. Keating
机构：
[1] Adis International Inc.,
来源：
BioDrugs | 2005年 / 19卷
关键词：
Breast Cancer; Acute Myeloid Leukemia; Febrile Neutropenia; Filgrastim; Chemotherapy Cycle;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Pegfilgrastim (Neulasta®), the sustained-duration form of filgrastim (recombinant human granulocyte colony-stimulating factor [G-CSF]), is created by the addition of a polyethylene glycol (PEG) moiety to filgrastim. Its approved indication in the US is to decrease the incidence of infection, as manifested by febrile neutropenia, in patients with non-myeloid malignancies receiving myelosuppressive chemotherapy.
引用
收藏
页码：405 / 407
页数：2
相关论文
共 50 条
  • [41] Risk of chemotherapy-induced febrile neutropenia in cancer patients receiving pegfilgrastim prophylaxis: does timing of administration matter?
    Weycker, Derek
    Li, Xiaoyan
    Figueredo, Jacqueline
    Barron, Rich
    Tzivelekis, Spiros
    Hagiwara, May
    SUPPORTIVE CARE IN CANCER, 2016, 24 (05) : 2309 - 2316
  • [42] Chemotherapy-induced neutropenia and febrile neutropenia in patients with gynecologic malignancy
    Hashiguchi, Yasunori
    Kasai, Mari
    Fukuda, Takeshi
    Ichimura, Tomoyuki
    Yasui, Tomoyo
    Sumi, Toshiyuki
    ANTI-CANCER DRUGS, 2015, 26 (10) : 1054 - 1060
  • [43] FLUCONAZOLE FOR ANTIFUNGAL PROPHYLAXIS IN CHEMOTHERAPY-INDUCED NEUTROPENIA
    PRESTON, SL
    BRICELAND, LL
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 1995, 52 (02) : 164 - 173
  • [44] Risk models for predicting chemotherapy-induced neutropenia
    Lyman, GH
    Lyman, CH
    Agboola, O
    ONCOLOGIST, 2005, 10 (06): : 427 - 437
  • [45] LITHIUM-CARBONATE IN CHEMOTHERAPY-INDUCED NEUTROPENIA
    MEISLER, AI
    NEW ENGLAND JOURNAL OF MEDICINE, 1977, 297 (21): : 1179 - 1180
  • [46] Lipegfilgrastim for the prophylaxis and treatment of chemotherapy-induced neutropenia
    Ratti, Margherita
    Tomasello, Gianluca
    EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2015, 8 (01) : 15 - 24
  • [47] Protease inhibitors potentiate chemotherapy-induced neutropenia
    Bower, M
    McCall-Peat, N
    Ryan, N
    Davies, L
    Young, AM
    Gupta, S
    Nelson, M
    Gazzard, B
    Stebbing, J
    BLOOD, 2004, 104 (09) : 2943 - 2946
  • [48] PROTECTION FROM CHEMOTHERAPY-INDUCED NEUTROPENIA BY IMUVERT
    JIMENEZ, JJ
    HUSSEIN, AM
    HINDAHL, M
    PEARSON, FC
    YUNIS, AA
    CLINICAL RESEARCH, 1991, 39 (02): : A171 - A171
  • [49] PROTECTION FROM CHEMOTHERAPY-INDUCED NEUTROPENIA BY IMUVERT
    JIMENEZ, JJ
    HUANG, HS
    HINDAHL, M
    PEARSON, FC
    YUNIS, AA
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 1992, 303 (02): : 83 - 85
  • [50] Hematopoietic growth factors for chemotherapy-induced neutropenia
    Yalçin, S
    CANCER INVESTIGATION, 1999, 17 (07) : 555 - 555
12345